Skip to main content

Advertisement

Table 4 Chemotherapy response assessment

From: Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer

  Differentiation status PLR NLR cNPS cNPLDS
well/moderate poor ≤223 > 223 ≤3.04 > 3.04 1 2 3 1–2 3–4 6–9
Total 46 90 89 47 81 55 69 32 35 27 55 54
CR 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
PR 3 (6.52%) 4 (4.44%) 4 (4.49%) 3 (6.38%) 3 (3.70%) 4 (7.27%) 2 (2.90%) 3 (9.38%) 2 (5.71%) 2 (7.41%) 1 (1.82%) 4 (7.41%)
SD 36 (78.26%) 64 (71.11%) 72 (80.89%) 28 (59.57%) 68 (83.95%) 32 (58.18%) 59 (85.51%) 22 (68.75%) 17 (48.57%) 23 (85.19%) 46 (83.64%) 31 (57.41%)
PD 7 (15.21%) 22 (24.44%) 13 (14.61%) 16 (34.04%) 10 (12.34%) 19 (34.55%) 8 (11.59%) 7 (21.87%) 14 (40%) 2 (7.41%) 8 (14.55%) 19 (35.19%)
DCR 84.78% 75.56% 85.39% 65.96% 87.65% 65.45% 88.40% 78.13% 60% 92.59% 85.45% 64.81%
P 0.214 0.008 0.002 0.004 0.004